Standardized Adaptive Music Medicine for Suicidality (STAMM-S)
20. maj 2026 opdateret af: Daniel Bowling, Stanford University
The primary goal of this clinical trial is to test if music-based intervention (STAMM-S) works for individuals with suicidal thoughts or behaviors. The main questions it aims to answer are:
- Can implementing specific music to listen to for 20 minutes a day for 25 days improve suicidality?
- Can implementing education around the psychology of the medicine of music improve mental health outcomes?
Participants will:
- Listen to music given to them by the study team for 20 minutes a day for 25 days
- Receive musical psychoeducation on how to improve mood using music
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
28
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
California
-
Palo Alto, California, Forenede Stater, 94304
- Yuukis Hall - Stanford University
-
Ledende efterforsker:
- Daniel L Bowling, PhD
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Age 14-35 years
- Suicidal ideation (C-SSRS categories 1-3 within the past month)
- normal sensitivity to music reward on the Barcelona Music Reward Questionnaire. Score >65
Exclusion Criteria:
- imminent or acute suicide risk (C-SSRS categories 4-5).
- Co-morbid substance use disorder.
- Co-morbid psychotic disorder.
- current participation in another trial
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: STAMM-S
Participants receive musical psychoeducation and take a dose of 20 minutes of adaptive music per day for 25 days.
|
Participants will undergo the STAMM-S treatment, which involves music generated using machine learning to move to a more positive affect.
They will also receive education on how to best use the music assigned to improve their mood.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Suicidality via Beck Scale for Suicidal Ideation (BSS/BSSI) Score
Tidsramme: Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
A 19-item scale with each item scoring from 0-2 rating an individual's suicidal thoughts, intent, and ideation.
The total score ranges from 0 to 38.
A higher score indicates more intense suicidal ideation and a low score indicates less intense suicidal ideation.
|
Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
|
Change in Generalized Anxiety Disorder Status via Generalized Anxiety Disorder-7 (GAD-7) Score
Tidsramme: Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
A 7-item measure scaled 0-3 per item that measures symptoms of Generalized Anxiety Disorder.
0 would be no sign of anxiety and 3 would indicate high level of anxiety over the last two weeks.
|
Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
|
Change in Depression Status via Patient Health Questionnaire-9 (PHQ-9) Score
Tidsramme: Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
A 9-item questionnaire that measures symptoms of depression on a 0-3 scale over the last two weeks.
0 would indicate "not at all", 1 would indicate "several days", 2 would indicate "most of the days", and a 3 would indicate "nearly every day".
|
Baseline, week 1, week 2, week 3, and post-trial interview (up to 25 days).
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Music Listening Purpose via Healthy-Unhealthy Music Scale (HUMS) - Healthy Score
Tidsramme: Baseline, end of study (up to 25 days).
|
Participants respond to a 5-question survey.
The scale ranges from 5 to 25.
For the healthy scale, a higher rating means a healthier use of music.
|
Baseline, end of study (up to 25 days).
|
|
Change in Music Listening Purpose via Healthy-Unhealthy Music Scale (HUMS) - Unhealthy Score
Tidsramme: Baseline, end of study (up to 25 days).
|
Participants respond to an 8-question survey.
The scale ranges 8 to 40.
A higher rating for the unhealthy scale indicates a more maladaptive use of music.
|
Baseline, end of study (up to 25 days).
|
|
Acceptability Scale Score
Tidsramme: At the end of the intervention (25 days after enrollment).
|
A 7-question questionnaire on a scale of 0-7 covering the 7 core components on intervention acceptability, where a 0 would indicate total unacceptability and 7 would equal total acceptability.
Single participant rating of 4 or greater will be interpreted as satisfactory acceptability.
|
At the end of the intervention (25 days after enrollment).
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Daniel L. Bowling, PhD, Stanford University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. juni 2026
Primær færdiggørelse (Anslået)
1. maj 2027
Studieafslutning (Anslået)
1. maj 2027
Datoer for studieregistrering
Først indsendt
20. maj 2026
Først indsendt, der opfyldte QC-kriterier
20. maj 2026
Først opslået (Faktiske)
28. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
28. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
20. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 86501
- ECR-0-025-24 (Andet bevillings-/finansieringsnummer: American Foundation for Suicide Prevention)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .